3
Announcements
Trials
Browse
Landscape
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Lymphoma
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Squamous Cell
2
Brain Neoplasms
2
Adenocarcinoma
2
Urticaria
1
Tuberous Sclerosis
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking
1
Small Cell Lung Carcinoma
1
Severe Combined Immunodeficiency
1
Sarcoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Dysautonomias
1
Polycythemia Vera
1
Polycythemia
1
Polycystic Ovary Syndrome
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Ovarian Neoplasms
1
Interventions
fludarabine
2
Fingolimod Hydrochloride
2
Cyclophosphamide
2
Blood Specimen Collection
2
teriflunomide
1
gadobutrol
1
gadobenic acid
1
Surveys and Questionnaires
1
Specimen Handling
1
Respiratory Therapy
1
Registries
1
Platelet Transfusion
1
Phlebotomy
1
OM 89
1
Nivolumab
1
Natalizumab
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Interferon beta-1a
1
Gadolinium DTPA
1
Fish Oils
1
Exergaming
1
Dimethyl Fumarate
1
Dietary Fiber
1
Data Collection
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Multiple Sclerosis
×
Phlebotomy
×
Clear all
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled